ganaxolone
Marketedupdated 2mo agoby Marinus Pharmaceuticals Inc
Approvedcommunity read0 votes
indications
investigational
Epilepsy
all catalysts(8)
approval · 8
Mar 18, 2022
approval
ZTALMY (GANAXOLONE) — FDA approval
ganaxolone
→
Nov 9, 2022
approval
ZTALMY (GANAXOLONE) — FDA approval
ganaxolone
→
Nov 9, 2022
approval
ZTALMY (GANAXOLONE) — FDA approval
ganaxolone
→
Jun 21, 2023
approval
ZTALMY (GANAXOLONE) — FDA approval
ganaxolone
→
Jun 21, 2023
approval
ZTALMY (GANAXOLONE) — FDA approval
ganaxolone
→
Aug 6, 2025
approval
ZTALMY (GANAXOLONE) — FDA approval
ganaxolone
→
Oct 16, 2025
approval
ZTALMY (GANAXOLONE) — FDA approval
ganaxolone
→
Oct 16, 2025
approval
ZTALMY (GANAXOLONE) — FDA approval
ganaxolone
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that